IL97242A0 - Xanthene propanoic acid derivative analogs,process for their preparation and pharmaceutical compositions containing them - Google Patents
Xanthene propanoic acid derivative analogs,process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL97242A0 IL97242A0 IL97242A IL9724291A IL97242A0 IL 97242 A0 IL97242 A0 IL 97242A0 IL 97242 A IL97242 A IL 97242A IL 9724291 A IL9724291 A IL 9724291A IL 97242 A0 IL97242 A0 IL 97242A0
- Authority
- IL
- Israel
- Prior art keywords
- xanthene
- preparation
- pharmaceutical compositions
- compositions containing
- acid derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/88—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
- C07D311/86—Oxygen atoms, e.g. xanthones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/481,413 US4996230A (en) | 1990-02-16 | 1990-02-16 | Leukotriene antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IL97242A0 true IL97242A0 (en) | 1992-05-25 |
Family
ID=23911845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL97242A IL97242A0 (en) | 1990-02-16 | 1991-02-14 | Xanthene propanoic acid derivative analogs,process for their preparation and pharmaceutical compositions containing them |
Country Status (20)
Country | Link |
---|---|
US (1) | US4996230A (ko) |
EP (1) | EP0442748B1 (ko) |
JP (1) | JPH04211037A (ko) |
KR (1) | KR910015558A (ko) |
CN (1) | CN1028639C (ko) |
AR (1) | AR247205A1 (ko) |
AT (1) | ATE116980T1 (ko) |
AU (1) | AU631482B2 (ko) |
CA (1) | CA2036523A1 (ko) |
DE (1) | DE69106545T2 (ko) |
FI (1) | FI910728A (ko) |
HU (1) | HU208431B (ko) |
IE (1) | IE910531A1 (ko) |
IL (1) | IL97242A0 (ko) |
NO (1) | NO177097C (ko) |
NZ (1) | NZ237124A (ko) |
PT (1) | PT96760A (ko) |
RU (1) | RU2007401C1 (ko) |
YU (1) | YU27691A (ko) |
ZA (1) | ZA911111B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH30449A (en) * | 1991-11-25 | 1997-05-28 | Lilly Co Eli | Substituted phenyl phenol leukotriene antagonists |
US5352690A (en) * | 1992-07-01 | 1994-10-04 | Eli Lilly And Company | 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
CA2142735A1 (en) * | 1993-06-18 | 1995-01-05 | Tatsuyoshi Tanaka | Fluorenone derivatives, process for preparing the same and central or peripheral nerve degeneration repair and protective agent |
WO1996011925A1 (en) * | 1994-10-13 | 1996-04-25 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists |
US6051601A (en) * | 1994-10-13 | 2000-04-18 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
US5977077A (en) * | 1995-08-28 | 1999-11-02 | Interlab Corporation | Xanthone analogs for the treatment of infectious diseases |
CA2199104A1 (en) | 1996-03-05 | 1997-09-05 | Tsuneaki Hida | Xanthene derivatives, their production and use |
AU4515701A (en) | 1999-12-02 | 2001-06-18 | Interlab, Inc. | Xanthone analogs for treating infectious diseases and complexation of heme and porphyrins |
US20060019269A1 (en) * | 2002-10-17 | 2006-01-26 | Decode Genetics, Inc. | Susceptibility gene for myocardial infarction, stroke, and PAOD, methods of treatment |
US20080293750A1 (en) * | 2002-10-17 | 2008-11-27 | Anna Helgadottir | Susceptibility Gene for Myocardial Infarction, Stroke, Paod and Methods of Treatment |
US20100216863A1 (en) * | 2004-01-30 | 2010-08-26 | Decode Genetics Ehf. | Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment |
US8158362B2 (en) * | 2005-03-30 | 2012-04-17 | Decode Genetics Ehf. | Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype |
CN112285355B (zh) * | 2020-10-20 | 2023-01-13 | 四川大学华西医院 | Viridiflorin检测试剂在制备COPD诊断试剂盒中的用途 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7008627A (ko) * | 1969-06-25 | 1970-12-29 | ||
US3987088A (en) * | 1971-09-08 | 1976-10-19 | Burroughs Wellcome Co. | Cyclic carbonyl compounds |
FR2278331A1 (fr) * | 1974-01-24 | 1976-02-13 | Roussel Uclaf | Nouveaux acides carboxyliques et leurs derives, leur application comme medicaments et leur procede de preparation |
US4166819A (en) * | 1975-09-24 | 1979-09-04 | Abbott Laboratories | 4-Aroyl substituted phenoxy methylene-5-tetrazoles |
GB1543964A (en) * | 1976-04-08 | 1979-04-11 | Ici Ltd | Method of antagonising herbicides on soyabean and cotton |
AU566167B2 (en) * | 1982-04-27 | 1987-10-08 | Wellcome Foundation Limited, The | Xanthene derivatives |
SE8400239D0 (sv) * | 1984-01-19 | 1984-01-19 | Pharmacia Ab | Nya arylettiksyraderivat |
US4661607A (en) * | 1984-09-21 | 1987-04-28 | Chugai Seiyaku Kabushiki Kaisha | Furoxanthone derivatives useful as diuretics |
ES2061518T3 (es) * | 1986-12-23 | 1994-12-16 | Warner Lambert Co | Compuestos que tienen propiedades antitumorales y antibacterianas. |
CA1320490C (en) * | 1987-01-12 | 1993-07-20 | Darrel M. Gapinski | Anti-inflammatory agents |
US5242121A (en) * | 1991-08-23 | 1993-09-07 | Roto-Mix Enterprises, Ltd. | Bale support and cutter |
-
1990
- 1990-02-16 US US07/481,413 patent/US4996230A/en not_active Ceased
-
1991
- 1991-02-13 KR KR1019910002539A patent/KR910015558A/ko not_active Application Discontinuation
- 1991-02-14 FI FI910728A patent/FI910728A/fi unknown
- 1991-02-14 ZA ZA911111A patent/ZA911111B/xx unknown
- 1991-02-14 DE DE69106545T patent/DE69106545T2/de not_active Expired - Fee Related
- 1991-02-14 JP JP3042992A patent/JPH04211037A/ja not_active Withdrawn
- 1991-02-14 PT PT96760A patent/PT96760A/pt not_active Application Discontinuation
- 1991-02-14 NZ NZ237124A patent/NZ237124A/en unknown
- 1991-02-14 CN CN91100939A patent/CN1028639C/zh not_active Expired - Fee Related
- 1991-02-14 EP EP91301217A patent/EP0442748B1/en not_active Expired - Lifetime
- 1991-02-14 IL IL97242A patent/IL97242A0/xx unknown
- 1991-02-14 AR AR91319057A patent/AR247205A1/es active
- 1991-02-14 AT AT91301217T patent/ATE116980T1/de active
- 1991-02-15 HU HU91521A patent/HU208431B/hu not_active IP Right Cessation
- 1991-02-15 NO NO910608A patent/NO177097C/no unknown
- 1991-02-15 AU AU71103/91A patent/AU631482B2/en not_active Ceased
- 1991-02-15 YU YU27691A patent/YU27691A/sh unknown
- 1991-02-15 RU SU914894418A patent/RU2007401C1/ru active
- 1991-02-15 IE IE053191A patent/IE910531A1/en unknown
- 1991-02-18 CA CA002036523A patent/CA2036523A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69106545D1 (de) | 1995-02-23 |
FI910728A (fi) | 1991-08-17 |
NO910608L (no) | 1991-08-19 |
JPH04211037A (ja) | 1992-08-03 |
EP0442748B1 (en) | 1995-01-11 |
DE69106545T2 (de) | 1995-06-01 |
US4996230A (en) | 1991-02-26 |
RU2007401C1 (ru) | 1994-02-15 |
ATE116980T1 (de) | 1995-01-15 |
HUT56359A (en) | 1991-08-28 |
CA2036523A1 (en) | 1991-08-17 |
FI910728A0 (fi) | 1991-02-14 |
EP0442748A1 (en) | 1991-08-21 |
AR247205A1 (es) | 1994-11-30 |
NO910608D0 (no) | 1991-02-15 |
HU208431B (en) | 1993-10-28 |
KR910015558A (ko) | 1991-09-30 |
NO177097B (no) | 1995-04-10 |
NO177097C (no) | 1995-07-19 |
NZ237124A (en) | 1992-04-28 |
YU27691A (sh) | 1994-04-05 |
ZA911111B (en) | 1992-10-28 |
PT96760A (pt) | 1991-11-29 |
AU631482B2 (en) | 1992-11-26 |
IE910531A1 (en) | 1991-08-28 |
AU7110391A (en) | 1991-08-22 |
CN1054066A (zh) | 1991-08-28 |
CN1028639C (zh) | 1995-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL103126A (en) | 5-amino-4-hydroxyhexanoic acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUT61989A (en) | Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient | |
HUT46699A (en) | Process for producing phosphinic acid derivatives and pharmaceutical compositions containing them as active components | |
HUT43825A (en) | Process for producing quinolon-carboxylic acid derivatives and pharmaceutical compositions containing them | |
HUT71106A (en) | Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
DE3165428D1 (en) | Substituted azobicyclooctanecarboxylic acids, process for their preparation und pharmaceutical compositions containing them | |
IL115072A (en) | Pharmaceutical compositions containing substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation some such new compounds and process for their preparation | |
IL97242A0 (en) | Xanthene propanoic acid derivative analogs,process for their preparation and pharmaceutical compositions containing them | |
HUT48902A (en) | Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them | |
HUT72319A (en) | Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation | |
IL87856A0 (en) | Alkadiene derivatives,process for their preparation and pharmaceutical compositions containing them | |
HUT46534A (en) | Process for producing pharmaceutical composition containing benzopirane-2-carboxylik acid derivative | |
HUT48460A (en) | Process for producing pharmaceutical compositions containing piperidinio-alkanol derivatives | |
IL104654A0 (en) | Phosphonic acid derivatives,process for their preparation and herbicidal compositions containing them | |
ZA966154B (en) | Aminophenylphosphonic acid compounds process for preparing them and pharmaceutical compositions containing them | |
HUT49361A (en) | Process for producing piperazinecarboxylic acid derivative and pharmaceutical compositions comprising this compound | |
GR890100177A (en) | Process for preparing pharmaceutical compositions containing sodium cromoclycate | |
HUT47077A (en) | Process for producing hydrocinnamomic acid derivatives and pharmaceutical compositions containing them as active components | |
HU900210D0 (en) | Herbicid composition comprising n-phenyl-tetrahydroindazol-derivatives as active ingredient acid process for preparation thereof | |
DE3380875D1 (en) | Piperidine-3-carboxylic acid derivatives, process for their preparation, and pharmaceutical compositions containing them | |
HUT56498A (en) | Process for producing pharmaceutical compositions having antiviral effect, containing benzylphosphonic acid derivatives | |
HUT50324A (en) | Process for producing thiophene-2-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds | |
IL82333A (en) | Substituted 2-phenylbenzothiazin-3-one derivatives,process for their preparation and pharmaceutical compositions containing them | |
IL106011A0 (en) | Substituted(benzothiazolyl-and quinoxalyl-methoxy)-phenyl-acetic acid derivatives,their preparation and pharmaceutical compositions containing them | |
HUT48272A (en) | Process for producing nukleinic acid derivatives and pharmaceutical compositions containing them |